Format

Send to

Choose Destination
See comment in PubMed Commons below
Oncologist. 2013;18(11):1167-73. doi: 10.1634/theoncologist.2013-0167. Epub 2013 Oct 17.

Breast cancer multifocality and multicentricity and locoregional recurrence.

Author information

1
Division of Cancer Medicine and.

Abstract

The impact of multifocal (MF) or multicentric (MC) breast cancer on locoregional (LR) control rates is unknown.

METHODS:

MF was defined as two or more separate invasive tumors in the same quadrant of the breast. MC was defined as two or more separate invasive tumors occupying more than one quadrant of the same breast. Patients were categorized by LR treatment: breast conservation therapy (BCT; n = 256), mastectomy (n = 466), or mastectomy plus postmastectomy radiation therapy (PMRT; n = 184). All patients with MC disease had mastectomy (10 patients treated with BCT for MC disease were excluded). The Kaplan-Meier product limit method was used to calculate 5-year LR control rate. Cox proportional hazards models were used to determine independent associations of multifocality or multicentricity with LR control.

RESULTS:

A total of 906 patients had either MF disease (n = 673) or MC disease (n = 233). With median follow-up of 52 months, the 5-year LR control rate was 99% for MF, 96% for MC, and 98% for unifocal tumors (p = .44). Subset analysis revealed no difference in LR control regardless of the LR treatment (p = .67 for BCT, p = .37 for mastectomy, p = .29 for mastectomy plus PMRT). There were five in-breast recurrences after BCT in the MF group. MF and MC did not have an independent impact on LR control rate on multivariate analysis.

CONCLUSION:

MF and MC disease are not independent risk factors for LR recurrence. Patients with MF and MC breast cancer had rates of LR control similar to those of their unifocal counterparts. These data suggest that BCT is a safe option for patients with MF tumors and that MF or MC disease alone is not an indication for PMRT.

KEYWORDS:

Breast cancer; Locoregional; Multicentric; Multifocal; Outcomes

PMID:
24136008
PMCID:
PMC3825299
DOI:
10.1634/theoncologist.2013-0167
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center